Lofexidine and Pasireotide: Interaction Details
- Lofexidine
- Lucemyra
- Pasireotide
- Signifor
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Lofexidine and Pasireotide interaction:
Pasireotide
- Signifor
We don't have a drug information page for Pasireotide yet. Have a question about Pasireotide? Ask a pharmacist, free →
What Happens When You Take Lofexidine With Pasireotide
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Lofexidine can lengthen the . When lofexidine was added in patients already stabilized on buprenorphine or methadone, both of which can prolong the QT interval, QTcF rose by 15 milliseconds and 9.1 milliseconds, respectively. monitoring is advised for patients who are also receiving other drugs that prolong the QT interval.1
The Lofexidine and Pasireotide Interaction, Explained
Both of these medicines can affect your heart's electrical rhythm. Lofexidine (used to ease withdrawal symptoms) and pasireotide (used for Cushing's disease or acromegaly) can each lengthen a part of the heartbeat cycle called the . Taking them together may add to that effect and raise the chance of an irregular heart rhythm. Signs to watch for include fainting, a racing or pounding heartbeat, or severe dizziness.
This does not mean you can't take both. Your care team can check your heart tracing () and keep an eye on you. Keep taking your medicines as prescribed, and talk with your pharmacist or doctor about any heart problems or other medicines you take.
() between lofexidine and pasireotide. Both agents are associated with QT prolongation; this is not a -mediated interaction, and neither drug's exposure is expected to change.
- Data: Lofexidine added to buprenorphine or methadone increased QTcF by 15 ms and 9.1 ms, respectively. Evidence for this specific pairing is extrapolated from the labeled QT warning (probable).
- Onset: unspecified.
- Management: Obtain monitoring with QT-prolonging drugs. Consider baseline and follow-up ECGs, and correct and . Be cautious with , congenital long QT, or other QT-prolonging agents.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Lofexidine and Pasireotide Interact
The likely mechanism
How to Manage the Lofexidine and Pasireotide Interaction
Your care team can manage this, mainly by monitoring your heart.
- monitoring: The documented advice is to monitor ECG in people taking more than one QT-prolonging drug, so your team may check your heart tracing.
- Keep taking both as prescribed. Do not stop or change either one on your own.
- Tell your pharmacist or prescriber about any heart rhythm problems, a slow heartbeat, low potassium or magnesium, and all other medicines you use.
- Seek help promptly for fainting, a racing or irregular heartbeat, or severe dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Lofexidine or Pasireotide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: LUCEMYRA oral tablets, lofexidine oral tablets
In a study of 18 patients who were maintained on methadone (80 to 120 mg/day), concurrent administration of lofexidine (2.88 mg/day) produced a maximum mean QTcF increase of 9.1 milliseconds relative to the baseline measured with methadone alone.1
-
Report 2 · Study title
Prescribing information: LUCEMYRA oral tablets, lofexidine oral tablets
In a study of 21 patients who were maintained on buprenorphine (16 to 24 mg/day), concurrent administration of lofexidine (2.88 mg/day) produced a maximum mean QTcF increase of 15 milliseconds relative to the baseline measured with buprenorphine alone.1
Lofexidine and Pasireotide: Common Questions
How serious is the Lofexidine and Pasireotide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Lofexidine and Pasireotide interaction managed?
Your care team can manage this, mainly by monitoring your heart. monitoring: The documented advice is to monitor ECG in people taking more than one QT-prolonging drug, so your team may check your heart tracing. Keep taking both as prescribed. Do not stop or change either one on your own. Tell your pharmacist or prescriber about any heart rhythm problems, a slow heartbeat, low potassium or magn… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Lofexidine and Pasireotide Interaction
Ask in your own words about taking Lofexidine and Pasireotide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: LUCEMYRA(TM) oral tablets, lofexidine oral tablets. US WorldMeds LLC (per FDA), Louisville, KY, 2018. DailyMed
Other Serious Interactions of Lofexidine and Pasireotide
Also serious with Lofexidine
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PimozideContraindicated
- ThioridazineContraindicated
Also serious with Pasireotide
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.